Clinical Trials Directory

Trials / Completed

CompletedNCT03491722

Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population

Evolution of Risk Factors and Revascularization Among >1 Decade Survivors After Coronary Revascularization in the Middle East

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Jordan Collaborating Cardiology Group · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The study will look at the cardiovascular risk factors as they arise, as well at the need for further revascularization after at least 10 years of coronary revascularization in Middle Eastern patients. The PI will overlook the whole process. Dr Ahmad Tamari, the assistant to the PI will asses this whole process of data collection, management and manuscript drafting.

Detailed description

Middle Eastern patients aged 18 years or above presenting to cardiology service at one tertiary care center who had coronary revascularization (stent or coronary bypass surgery, i.e., index procedure) at least 10 years back, will interviewed to determine: 1. Evolution of cardiovascular risk factors in the period from index procedure to time of interview. These risk factors include; hypertension, diabetes, smoking, dyslipidemia and obesity. 2. Need for further arterial revascularization from the index procedure to time of interview. These arterial revascularization procedures include A. Coronary: stent and/or bypass surgery B. Carotid endarterectomy. C. peripheral arterial revascularization D. Renal artery stent. 3. Medications used at the time if interview with special emphases on the guideline-recommended medications including antiplatelet agents, beta blockers, statins and renin angiotensin blockers.

Conditions

Interventions

TypeNameDescription
OTHERrisk factors and revascularization proceduresarterial revascularizations needed since index procedure

Timeline

Start date
2018-06-01
Primary completion
2019-06-10
Completion
2019-06-10
First posted
2018-04-09
Last updated
2023-05-25

Locations

2 sites across 1 country: Jordan

Source: ClinicalTrials.gov record NCT03491722. Inclusion in this directory is not an endorsement.